These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 10563653)

  • 1. APOE-491 promoter polymorphism is a risk factor for late-onset Alzheimer's disease.
    Casadei VM; Ferri C; Veglia F; Gavazzi A; Salani G; Cattaneo M; Sorbi S; Annoni G; Licastro F; Mariani C; Franceschi M; Grimaldi LM
    Neurology; 1999 Nov; 53(8):1888-9. PubMed ID: 10563653
    [No Abstract]   [Full Text] [Related]  

  • 2. Apolipoprotein E promoter polymorphism and sporadic Alzheimer's disease in a Japanese population.
    Toji H; Maruyama H; Sasaki K; Nakamura S; Kawakami H
    Neurosci Lett; 1999 Jan; 259(1):56-8. PubMed ID: 10027555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No association of the -48CT polymorphism of the presenilin 1 gene with Alzheimer disease in a late-onset sporadic population.
    Araria-Goumidi L; Huguet JB; Lambert JC; Frigard B; Cottel D; Amouyel P; Chartier-Harlin MC
    J Neural Transm (Vienna); 2002 Jul; 109(7-8):1023-7. PubMed ID: 12111439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of APOE genotype and promoter polymorphism on risk of Alzheimer's disease.
    Wang JC; Kwon JM; Shah P; Morris JC; Goate A
    Neurology; 2000 Dec; 55(11):1644-9. PubMed ID: 11113217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms of the apolipoprotein E gene regulatory region and of the LDL receptor gene in late-onset Alzheimer's disease in relation to the plasma lipidic pattern.
    Scacchi R; Gambina G; Martini MC; Ruggeri M; Ferrari G; Silvestri M; Schiavon R; Corbo RM
    Dement Geriatr Cogn Disord; 2001; 12(2):63-8. PubMed ID: 11173876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. APOE promoter polymorphisms do not confer independent risk for Alzheimer's disease in a French population.
    Zurutuza L; Verpillat P; Raux G; Hannequin D; Puel M; Belliard S; Michon A; Pothin Y; Camuzat A; Penet C; Martin C; Brice A; Campion D; Clerget-Darpoux F; Frebourg T
    Eur J Hum Genet; 2000 Sep; 8(9):713-6. PubMed ID: 10980578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-6 promoter polymorphism and late-onset Alzheimer's disease in the Finnish population.
    Koivisto AM; Helisalmi S; Pihlajamäki J; Moilanen L; Kuusisto J; Laakso M; Hiltunen M; Keijo K; Hänninen T; Helkala EL; Kervinen K; Kesäniemi YA; Soininen H
    J Neurogenet; 2005; 19(3-4):155-61. PubMed ID: 16540406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein E epsilon4 allele is a risk factor for Alzheimer's disease: the central region of portugal (Coimbra) as a case study.
    Fernandes MA; Oliveira CR; Oliveira LM; Nogueira AJ; Santiago B; Santana I
    Eur Neurol; 1999; 42(3):183-4. PubMed ID: 10529548
    [No Abstract]   [Full Text] [Related]  

  • 9. Risk for Alzheimer's disease correlates with transcriptional activity of the APOE gene.
    Artiga MJ; Bullido MJ; Frank A; Sastre I; Recuero M; García MA; Lendon CL; Han SW; Morris JC; Vázquez J; Goate A; Valdivieso F
    Hum Mol Genet; 1998 Nov; 7(12):1887-92. PubMed ID: 9811931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between glycogen synthase kinase-3beta genetic polymorphism and late-onset Alzheimer's disease.
    Mateo I; Infante J; Llorca J; Rodríguez E; Berciano J; Combarros O
    Dement Geriatr Cogn Disord; 2006; 21(4):228-32. PubMed ID: 16428884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin 6-174 G/C promoter and variable number of tandem repeats (VNTR) gene polymorphisms in sporadic Alzheimer's disease.
    Capurso C; Solfrizzi V; Colacicco AM; D'Introno A; Frisardi V; Imbimbo BP; Lorusso M; Vendemiale G; Denitto M; Santamato A; Seripa D; Pilotto A; Fiore P; Capurso A; Panza F
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):177-82. PubMed ID: 19897004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is there a relation between APOE expression and brain amyloid load in Alzheimer's disease?
    Lambert JC; Mann D; Richard F; Tian J; Shi J; Thaker U; Merrot S; Harris J; Frigard B; Iwatsubo T; Lendon C; Amouyel P
    J Neurol Neurosurg Psychiatry; 2005 Jul; 76(7):928-33. PubMed ID: 15965197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of association between the CYP46 gene polymorphism and Italian late-onset sporadic Alzheimer's disease.
    Tedde A; Rotondi M; Cellini E; Bagnoli S; Muratore L; Nacmias B; Sorbi S
    Neurobiol Aging; 2006 May; 27(5):773.e1-773.e3. PubMed ID: 16055229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promoter polymorphism in fibroblast growth factor 1 gene increases risk of definite Alzheimer's disease.
    Yamagata H; Chen Y; Akatsu H; Kamino K; Ito J; Yokoyama S; Yamamoto T; Kosaka K; Miki T; Kondo I
    Biochem Biophys Res Commun; 2004 Aug; 321(2):320-3. PubMed ID: 15358178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No association between the alpha-2 macroglobulin I1000V polymorphism and Alzheimer's disease.
    Wavrant-DeVrièze F; Rudrasingham V; Lambert JC; Chakraverty S; Kehoe P; Crook R; Amouyel P; Wu W; Holmans P; Rice F; Pérez-Tur J; Frigard B; Morris JC; Carty S; Cottel D; Tunstall N; Lovestone S; Petersen RC; Chartier-Harlin MC; Goate A; Owen MJ; Williams J; Hardy J
    Neurosci Lett; 1999 Mar; 262(2):137-9. PubMed ID: 10203250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new polymorphism in the APOE promoter associated with risk of developing Alzheimer's disease.
    Lambert JC; Pasquier F; Cottel D; Frigard B; Amouyel P; Chartier-Harlin MC
    Hum Mol Genet; 1998 Mar; 7(3):533-40. PubMed ID: 9467014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's risk associated with human apolipoprotein E, alpha-2 macroglobulin and lipoprotein receptor related protein polymorphisms: absence of genetic interactions, and modulation by gender.
    Bullido MJ; Guallar-Castillón P; Artiga MJ; Ramos MC; Sastre I; Aldudo J; Frank A; Coria F; Rodríguez-Artalejo F; Valdivieso F
    Neurosci Lett; 2000 Aug; 289(3):213-6. PubMed ID: 10961667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ApoE-epsilon 4 and early-onset Alzheimer's.
    Okuizumi K; Onodera O; Tanaka H; Kobayashi H; Tsuji S; Takahashi H; Oyanagi K; Seki K; Tanaka M; Naruse S
    Nat Genet; 1994 May; 7(1):10-1. PubMed ID: 8075630
    [No Abstract]   [Full Text] [Related]  

  • 19. High expression of apolipoprotein E mRNA in the brains with sporadic Alzheimer's disease.
    Yamagata K; Urakami K; Ikeda K; Ji Y; Adachi Y; Arai H; Sasaki H; Sato K; Nakashima K
    Dement Geriatr Cogn Disord; 2001; 12(2):57-62. PubMed ID: 11173875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variation at the APOE -491 promoter locus is associated with altered brain levels of apolipoprotein E.
    Laws SM; Hone E; Taddei K; Harper C; Dean B; McClean C; Masters C; Lautenschlager N; Gandy SE; Martins RN
    Mol Psychiatry; 2002; 7(8):886-90. PubMed ID: 12232782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.